序号 |
标题 |
次数 |
作者 |
发布时间 |
82171 |
BODIPY荧光硫甲基四嗪衍生物(BODIPY-TzSMe) |
231 |
WYQ |
2024-11-29 |
82172 |
四嗪修饰RGD肽c;RGDyK-Tz;RGDyK-tetrazine |
97 |
WYQ |
2024-11-29 |
82173 |
z-BODIPY-Halo;荧光BODIPY四嗪探针修饰蛋白靶向标记技术反应底物 |
161 |
WYQ |
2024-11-29 |
82174 |
731862-92-3,Mal-C6-amine TFA |
177 |
kx |
2024-11-29 |
82175 |
(己二酸-5-降冰片烯-2-甲酯)-(3,6-二氧杂-1,8-辛二硫醇)(PAND) |
162 |
h |
2024-11-29 |
82176 |
5-乙烯基-2-降冰片烯(VNB) |
429 |
h |
2024-11-29 |
82177 |
2-乙烯基-5-降冰片烯(VNB) |
163 |
h |
2024-11-29 |
82178 |
94885-04-8,C6NBD-神经鞘氨酯,C6 NBD Sphingomyelin (d18:1/6:0) |
108 |
kx |
2024-11-29 |
82179 |
降冰片烯二酸酐(XMNA) |
258 |
h |
2024-11-29 |
82180 |
5-降冰片烯-2,3-二羧酸二甲酯(DCNM) |
137 |
h |
2024-11-29 |
82181 |
5-降冰片烯-2-亚甲基-(6-溴己基)醚(NB-O-Br) |
147 |
h |
2024-11-29 |
82182 |
N-环庚基降冰片烯酰亚胺(CHepNDI) |
108 |
h |
2024-11-29 |
82183 |
5-降冰片烯-2-甲醇(NB-CH2OH) |
136 |
h |
2024-11-29 |
82184 |
Tz-BODIPY-MOR;氟化硼二吡咯-四嗪靶向溶酶体 |
126 |
|
2024-11-29 |
82185 |
5-降冰片烯-2-甲醛 |
128 |
h |
2024-11-29 |
82186 |
侧链双键的降冰片烯衍生物(ENB) |
198 |
h |
2024-11-29 |
82187 |
降冰片烯基三氟乙酯(NF) |
201 |
h |
2024-11-29 |
82188 |
2375774-54-0,Pomalidomide-C6-O-C5-O-C4-COOH |
129 |
kx |
2024-11-29 |
82189 |
3,6-二-2-吡啶基-1,2,4,5-四嗪 |
129 |
WYQ |
2024-11-29 |
82190 |
钯芳基降冰片烯五元环(ANP) |
146 |
h |
2024-11-29 |
82191 |
(2-氨基乙基)-吗啉基团偶联3-(吡啶-3-基)-6-氨基乙基-1,2,4,5-四嗪偶联(LysoTz) |
116 |
WYQ |
2024-11-29 |
82192 |
降冰片烯羧酸甲酯聚合物(P(exo-MeNB) |
101 |
h |
2024-11-29 |
82193 |
1578249-76-9,Mal-C6-α-Amanitin |
85 |
kx |
2024-11-29 |
82194 |
降冰片烯二酸酐-马来酰亚胺基七异丁基聚倍半硅氧烷交替共聚物 poly(MIPOSS-alt-NA) |
294 |
h |
2024-11-29 |
82195 |
5-丁氧基亚甲基-2-降冰片烯,双-(β-酮萘胺)镍(Ⅱ)/B(C6F5)3 |
119 |
h |
2024-11-29 |
82196 |
CAS:2921619-48-7;DOTA-方酸-PEG4(丙酸)-ONCOFAP |
156 |
zcy |
2024-11-29 |
82197 |
萘酰亚胺修饰聚降冰片烯共聚物P-NB-NA-PEG |
93 |
h |
2024-11-29 |
82198 |
聚乙叉降冰片烯二乙烯基联苯共聚物 |
154 |
h |
2024-11-29 |
82199 |
ROPARGYL-DOTA-TRIS(TBU)ESTER;基于NOTADOTA定制和偶联 |
122 |
zcy |
2024-11-29 |
82200 |
降冰片烯官能化聚丙烯酸叔丁酯(NB-PtBA) |
156 |
h |
2024-11-29 |
82201 |
聚降冰片烯纳米纤维(PNB) |
240 |
h |
2024-11-29 |
82202 |
TRI-TERT-BUTYL 1,4,7,10-TETRAAZACYCLODOD;三叔丁基-1,4,7,10-四氮杂环十二烷 |
130 |
zcy |
2024-11-29 |
82203 |
DOTA-3-酪氨酰基-奥曲肽(DOTA-3-Tyr-Octreotide) |
78 |
zcy |
2024-11-29 |
82204 |
94885-02-6, C6 NBD Ceramide |
144 |
kx |
2024-11-29 |
82205 |
DOTA-tris(TBE)-amido dPEG (R)11-Maleimide;基于NOTADOTA定制和偶联 |
151 |
zcy |
2024-11-29 |
82206 |
479081-06-6 , DOTA-(COOt-Bu)3-NHFmoc-Lys |
179 |
wyh |
2024-11-29 |
82207 |
DOTA-octreotide |
87 |
wyh |
2024-11-29 |
82208 |
CAS:127985-74-4 ,DOTA-p-NCS-Bn ,多肽标记的双功能螯合剂 |
219 |
wyh |
2024-11-29 |
82209 |
N-(2-溴代异丁酰溴基)-顺-5-降冰片烯-外-2,3-二甲酰亚胺(exo-BNDI) |
158 |
h |
2024-11-29 |
82210 |
cyclo(RGDFK(DOTA)) |
108 |
wyh |
2024-11-29 |
82211 |
DOTA-tris(acid)-amido-dPEG (R)24-amido-dPEG (R)24-DSPE 定制 |
164 |
zcy |
2024-11-29 |
82212 |
Lu-DOTA-TATE ;镥-大环配体-TATE多肽 |
132 |
wyh |
2024-11-29 |
82213 |
11,12-二脱氢-ε-氧代二苯并[b,f]氮杂环辛-5(6H)-己酸,DBCO-C6-acid |
124 |
kx |
2024-11-29 |
82214 |
降冰片烯改性聚乙烯醇(PVA) |
198 |
h |
2024-11-29 |
82215 |
DOTA-PEG-CPP , DOTA-聚乙二醇-酪蛋白磷酸肽 |
151 |
wyh |
2024-11-29 |